Bastiaan Sallevelt

91 Evaluation of clarity of the STOPP/START criteria - SI Table SI1.1. Continued. STOPP Action Clarity rating Condition Clarity rating Explanation Clarity rating M M1 Concomitant use of two or more drugs with antimuscarinic/ anticholinergic properties (e.g. bladder antispasmodics, intestinal antispasmodics, tricyclic antidepressants, first generation antihistamines) 25% [users with…concomitant use of two or more drugs with antimuscarinic/anticholinergic properties] 17% (risk of increased antimuscarinic/anticholinergic toxicity) 17% 2